Prof. Banafshé Larijani
University of Bath
H-index: 36
Europe-United Kingdom
Top articles of Prof. Banafshé Larijani
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Correction: Spatial functional mapping of hypoxia inducible factor heterodimerisation and immune checkpoint regulators in clear cell renal cell carcinoma | BJC Reports | Elena Safrygina Christopher Applebee Alan McIntyre Julian Padget Banafshé Larijani | 2024/3/26 |
Spatial functional mapping of hypoxia inducible factor heterodimerisation and immune checkpoint regulators in clear cell renal cell carcinoma | BJC Reports | Elena Safrygina Christopher Applebee Alan McIntyre Julian Padget Banafshé Larijani | 2024/2/9 |
981 AXL-targeted macrophage phenotype switching mediates checkpoint-resistance in melanoma | Amanda Kirane-c Saurabh Sharma Mamatha Serasanambati Mohammad Usman Ahmad Chris Applebee | 2023/11/1 | |
622 Immune phenotype and iFRET functional analysis are biomarkers of response to neoadjuvant intralesional therapy for high risk stage II melanoma | Amanda Kirane Michael C Lowe Mohammad Usman Ahmad Saurabh Sharma Mamatha Serasanambati | 2023/11/1 | |
The enigma of phosphoinositides and their derivatives: Their role in regulation of subcellular compartment morphology | Banafshé Larijani Lior Pytowski David J Vaux | 2022/2/1 | |
Determination of Interactive States of Immune Checkpoint Regulators in Lung Metastases after Radiofrequency Ablation | Cancers | James Miles Isabelle Soubeyran Florence Marliot Nicolas Pangon Antoine Italiano | 2022/11/22 |
The fusion of quantitative molecular proteomics and immune‐oncology: a step towards precision medicine in cancer therapeutics | James Miles Stephen G Ward Banafshé Larijani | 2022/11 | |
Label-free single-cell drug response determined by fluorescence lifetime imaging microscopy (FLIM) and RNA sequencing | Cancer Research | Ning Ma Hui Ren Naveen Ramalingam David King Banafshé Larijani | 2022/6/15 |
Quantification of protein-protein interactions and activation dynamics: A new path to predictive biomarkers | Biophysical Chemistry | Banafshé Larijani James Miles | 2022/4/1 |
Immunogenomics of colorectal cancer response to checkpoint blockade: analysis of the KEYNOTE 177 trial and validation cohorts | Gastroenterology | Michele Bortolomeazzi Mohamed Reda Keddar Lucia Montorsi Amelia Acha-Sagredo Lorena Benedetti | 2021/10/1 |
Quantification of biomarker functionality predicts patient outcomes | British journal of cancer | Banafshé Larijani James Miles Stephen G Ward Peter J Parker | 2021/5/11 |
Tandem NMR and mass spectrometry analysis of human nuclear membrane lipids | Analytical Chemistry | Régine Dazzoni Corinne Buré Estelle Morvan Axelle Grélard Céline Gounou | 2020/4/23 |
The unprecedented membrane deformation of the human nuclear envelope, in a magnetic field, indicates formation of nuclear membrane invaginations | Scientific reports | Régine Dazzoni Axelle Grélard Estelle Morvan Anthony Bouter Christopher J Applebee | 2020/3/20 |
Kits, methods and their uses for detecting cell-cell interactions in a sample kits | 2020/3/5 | ||
Methods for detecting molecules in a sample | 2020/3/3 | ||
Immunogenomic profile of colorectal cancer response to immune checkpoint blockade | bioRxiv | Michele Bortolomeazzi Mohamed Reda Keddar Lucia Montorsi Amelia Acha-Sagredo Lorena Benedetti | 2020/1/1 |
Immune-checkpoint engagement as predictive biomarkers in clear cell renal cell carcinoma and melanoma | medRxiv | Lissete Sánchez-Magraner James Miles Claire Baker Christopher J Applebee Dae-Jin Lee | 2020/1/16 |
High PD-1/PD-L1 checkpoint interaction infers tumor selection and therapeutic sensitivity to anti-PD-1/PD-L1 treatment | Cancer Research | Lissete Sánchez-Magraner James Miles Claire L Baker Christopher J Applebee Dae-Jin Lee | 2020/10/1 |
Co-Authors
